||Fifteen business collaborations, carrying out early-stage investigations into the feasibility of novel non-animal technologies, have received support from five key funding bodies, including the NC3Rs.
The development of non-animal technologies is vital in the search for alternatives that can replace the use of animals in scientific research. Fifteen feasibility studies, carried out by collaborations between companies and academia, will look at a range of non-animal technologies. The technologies capitalise upon recent advances in the biosciences and engineering including; induced pluripotent stem cells, tissue engineering technologies, high-throughput platforms, computational modelling, novel imaging techniques and bioprinting technologies.
The NC3Rs, the UK’s innovation agency, the Technology Strategy Board, the Biotechnology and Biological Sciences Research Council, the Defence Science and Technology Laboratory and the Engineering and Physical Sciences Research Council have joined forces to fund the business-led projects which have the potential to change both the drug development and chemical testing landscape.